LOS ANGELES, CA / ACCESSWIRE / May 31, 2018 / IsoRay, Inc. (NYSE American: ISR), a medical technology company
and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head and neck
and gynecological cancers, today announced that it will be presenting at the 8th annual LD Micro Invitational on Tuesday, June 5th
at 9:30 AM PST /12:30 PM EST. Tom LaVoy, CEO of IsoRay, will be giving the presentation and meeting with investors throughout the
conference.
"The event is slated to be our largest Invitational to date," stated Chris Lahiji, President of LD Micro. "When the fires caused
the cancellation of our Main Event back in December, we vowed to come back even stronger. This event showcases our firm's ability
to attract the most unique and exciting names in micro-cap."
The conference will be held at the Luxe Sunset Bel Air Hotel, will feature 230 companies in the small-cap/micro-cap space, and
will be attended by over 1,000 individuals.
View IsoRay's profile here: https://www.ldmicro.com/profile/ISR.
Profiles powered by LD Micro - News
Compliments of Accesswire.
About IsoRay, Inc.
IsoRay, Inc., through its subsidiary, IsoRay Medical, Inc., is the sole producer of Cesium-131 brachytherapy seeds, which are
expanding brachytherapy options throughout the body. Learn more about this innovative Richland, Washington company and explore the
many benefits and uses of Cesium-131 by visiting www.isoray.com. Join us on Facebook/IsoRay. Follow us on Twitter @IsoRay.
About LD Micro
LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. The firm hosts
several influential conferences annually (Invitational, Summit, and Main Event).
In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector.
LD will continue to provide valuable tools for the benefit of everyone in the small and micro-cap universe.
For those interested in attending, please contact David Scher at david@ldmicro.com or
visit www.ldmicro.com for more information.
Contacts:
IsoRay, Inc.
info@isoray.com
(509) 375-1202
Investors:
Stephanie Prince, Managing Director
PCG Advisory Group
sprince@pcgadvisory.com
(646) 762-4518
SOURCE: IsoRay
